← Back to patent-cliff list
马来酸噻吗洛尔
Tier C — Watch / tradeTimolol Maleate
Valeant
Originator
1978
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：β-adrenoceptors
Brand：Timoptol-la、Betim、Timosan、Rysmon TG、Istalol、Timolast、Timoptol-lp、Nyolol、Timoptic-XE、TIMOPTIC-PF、Blocadren、Timoptic、Timacor、Timoptol、Timoptol XE、Nyogel
Indications (approved)：高眼压、青光眼、开角型青光眼
Regional status
US
批准上市
1978-08-17
EU
-
China
批准上市
1983-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Timolol Maleate?
Approved indications include: 高眼压, 青光眼, 开角型青光眼.
When does the Timolol Maleate patent expire?
No public expiry year is available for Timolol Maleate yet; this page updates once verified.
How do I get a quote for Timolol Maleate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25